MX2018004221A - Vacuna heterologa atenuada viva para leptospira. - Google Patents

Vacuna heterologa atenuada viva para leptospira.

Info

Publication number
MX2018004221A
MX2018004221A MX2018004221A MX2018004221A MX2018004221A MX 2018004221 A MX2018004221 A MX 2018004221A MX 2018004221 A MX2018004221 A MX 2018004221A MX 2018004221 A MX2018004221 A MX 2018004221A MX 2018004221 A MX2018004221 A MX 2018004221A
Authority
MX
Mexico
Prior art keywords
leptospira
live attenuated
heterologous vaccine
compositions
recombinant
Prior art date
Application number
MX2018004221A
Other languages
English (en)
Inventor
Ines Bomchil Natalia
Pierre Christian Cupillard Lionel
Fontana Célia
Michel GUIGAL Pierre-
Bouvet Jérôme
Picardeau Mathieu
Kodjo Angeli
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of MX2018004221A publication Critical patent/MX2018004221A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención proporciona composiciones o vacunas que contienen una Leptospira interrogans recombinante o atenuada que induce una respuesta inmune en animales contra la infección de Leptospira, que incluye composiciones que comprenden la L. interrogans recombinante o atenuada, métodos de vacunación contra Leptospira, y kits para el uso con tales métodos y composiciones.
MX2018004221A 2015-10-08 2016-10-05 Vacuna heterologa atenuada viva para leptospira. MX2018004221A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562239136P 2015-10-08 2015-10-08
PCT/US2016/055508 WO2017062460A1 (en) 2015-10-08 2016-10-05 Live attenuated heterologous vaccine for leptospira

Publications (1)

Publication Number Publication Date
MX2018004221A true MX2018004221A (es) 2019-11-08

Family

ID=57211574

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004221A MX2018004221A (es) 2015-10-08 2016-10-05 Vacuna heterologa atenuada viva para leptospira.

Country Status (12)

Country Link
US (1) US11497802B2 (es)
EP (1) EP3359187A1 (es)
JP (2) JP6986019B2 (es)
CN (1) CN109414493A (es)
AU (2) AU2016333955B2 (es)
BR (1) BR112018007093A2 (es)
CA (1) CA3001340A1 (es)
HK (1) HK1254646A1 (es)
MX (1) MX2018004221A (es)
NZ (1) NZ742205A (es)
RU (1) RU2702835C1 (es)
WO (1) WO2017062460A1 (es)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
RU2049815C1 (ru) * 1992-05-13 1995-12-10 Научно-производственное объединение "Биопрепарат" Штамм бактерий leptospira interrogans, предназначенный для получения лептоспирозных вакцин
AU4992197A (en) 1996-10-11 1998-05-11 Regents Of The University Of California, The Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
PL1651265T3 (pl) 2003-07-24 2008-10-31 Merial Ltd Formulacje szczepionek zawierających emulsję olej w wodzie
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
MY157607A (en) 2009-09-10 2016-06-30 Merial Inc New vaccine formulations comprising saponin-containing adjuvants
CN101991864B (zh) * 2010-10-29 2012-10-17 中国人民解放军第二军医大学 一种问号钩端螺旋体dna疫苗及其构建方法和应用
UA91615U (uk) * 2014-02-14 2014-07-10 Інститут Ветеринарної Медицини Національної Академії Аграрних Наук України Вакцина проти лептоспірозу тварин полівалентна (варіант equi)
US10143735B2 (en) 2014-03-12 2018-12-04 Yale University Compositions and methods of preparing Leptospira

Also Published As

Publication number Publication date
BR112018007093A2 (pt) 2019-01-15
WO2017062460A1 (en) 2017-04-13
HK1254646A1 (zh) 2019-07-26
JP7253030B2 (ja) 2023-04-05
US11497802B2 (en) 2022-11-15
EP3359187A1 (en) 2018-08-15
JP2022033829A (ja) 2022-03-02
AU2019268149A1 (en) 2019-12-12
AU2016333955A1 (en) 2018-05-24
AU2016333955B2 (en) 2019-10-03
RU2702835C1 (ru) 2019-10-11
CN109414493A (zh) 2019-03-01
JP6986019B2 (ja) 2021-12-22
JP2018534354A (ja) 2018-11-22
CA3001340A1 (en) 2017-04-13
NZ742205A (en) 2019-09-27
US20180271966A1 (en) 2018-09-27

Similar Documents

Publication Publication Date Title
PH12017502233A1 (en) Formulations for neoplasia vaccines and methods of preparing thereof
PH12020500080A1 (en) Senecavirus a immunogenic compositions and methods thereof
MX2017001406A (es) Agentes a base de flagelina y usos de los mismos, incluyendo vacunación efectiva.
MA40061A (fr) Compositions immunogènes à base de listeria pour provoquer des réponses anti-tumorales
PH12015501716A1 (en) Anti-mycoplasma spp. subunit vaccine
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
SG11202003800YA (en) Zika vaccines and immunogenic compositions, and methods of using the same
NZ700470A (en) Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
SG11202004863QA (en) Zika vaccines and immunogenic compositions, and methods of using the same
MX2020005584A (es) Vacunacion con particulas de replicon y adyuvante oleoso.
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
ZA202103154B (en) Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same
PH12014501795B1 (en) Rotavirus subunit vaccines and methods of making and use thereof
MX2021007502A (es) Formulaciones y métodos de vacuna de norovirus.
EP3445398A4 (en) LIVE ATTENUATED VACCINE WITHOUT VIRULENCE FACTOR AND SUITABLE FOR COLD SUITABLE FOR MUCOSAL ADMINISTRATION
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
EA201792512A1 (ru) Составы для доставки антигенов респираторного синтициального вируса и норовируса в тонкий кишечник
NZ734938A (en) Leptospira immunoprotective proteins and methods of identification and use thereof
AU2019268149A1 (en) Live attenuated heterologous vaccine for Leptospira
IL282245A (en) Methods and compositions of polypeptide-based vaccines
KR102130925B9 (ko) 면역원성시스템 및 이를 포함한 동물 백신
PH12015500740A1 (en) Vaccination against japanese encephalitis, measles, mumps and rubella
MX2021001641A (es) Identificacion de proteinas inmunogenicas para el control de ectoparasitos.
NZ717406A (en) Attenuated mannheimia haemolytica vaccines and methods of making and use

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: INSTITUT PASTEUR